![Induction of labour at 41 weeks versus expectant management until 42 weeks (INDEX): multicentre, randomised non-inferiority trial | The BMJ Induction of labour at 41 weeks versus expectant management until 42 weeks (INDEX): multicentre, randomised non-inferiority trial | The BMJ](https://www.bmj.com/content/bmj/364/bmj.l344/F2.large.jpg)
Induction of labour at 41 weeks versus expectant management until 42 weeks (INDEX): multicentre, randomised non-inferiority trial | The BMJ
![Induction of labour versus expectant management for large-for-date fetuses: a randomised controlled trial - The Lancet Induction of labour versus expectant management for large-for-date fetuses: a randomised controlled trial - The Lancet](https://www.thelancet.com/cms/attachment/23b9854d-80ad-4736-99f3-6401416ffa57/gr1_lrg.gif)
Induction of labour versus expectant management for large-for-date fetuses: a randomised controlled trial - The Lancet
![PDF) Effects of induction of labour versus expectant management in women with impending post-term pregnancies: The 41 week - 42 week dilemma PDF) Effects of induction of labour versus expectant management in women with impending post-term pregnancies: The 41 week - 42 week dilemma](https://i1.rgstatic.net/publication/267739978_Effects_of_induction_of_labour_versus_expectant_management_in_women_with_impending_post-term_pregnancies_The_41_week_-_42_week_dilemma/links/55e016b508ae2fac4719430c/largepreview.png)
PDF) Effects of induction of labour versus expectant management in women with impending post-term pregnancies: The 41 week - 42 week dilemma
![Induction of labour at term with oral misoprostol versus a Foley catheter (PROBAAT-II): a multicentre randomised controlled non-inferiority trial - The Lancet Induction of labour at term with oral misoprostol versus a Foley catheter (PROBAAT-II): a multicentre randomised controlled non-inferiority trial - The Lancet](https://www.thelancet.com/cms/attachment/2053462743/2060237727/gr1.gif)